CN102512478A - Chronic pharyngitis oral liquid - Google Patents
Chronic pharyngitis oral liquid Download PDFInfo
- Publication number
- CN102512478A CN102512478A CN2011104365082A CN201110436508A CN102512478A CN 102512478 A CN102512478 A CN 102512478A CN 2011104365082 A CN2011104365082 A CN 2011104365082A CN 201110436508 A CN201110436508 A CN 201110436508A CN 102512478 A CN102512478 A CN 102512478A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- chronic pharyngitis
- dry powder
- moschus
- scorpio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 16
- 201000007100 Pharyngitis Diseases 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 241000972155 Moschus Species 0.000 claims description 8
- 241000522620 Scorpio Species 0.000 claims description 8
- 239000009490 scorpio Substances 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 2
- 206010004542 Bezoar Diseases 0.000 abstract 2
- 241000402754 Erythranthe moschata Species 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000245665 Taraxacum Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- 238000011084 recovery Methods 0.000 description 10
- 201000009151 chronic rhinitis Diseases 0.000 description 4
- 206010039083 rhinitis Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a chronic pharyngitis oral liquid, comprising 0.005-0.015 g of artificial bezoar, 0.005-0.015 g of musk, 0.25-0.75 g of whole worm, 0.25-0.75 g of dandelion powder, 0.1-0.3 g of honeysuckle powder, 40-80 g of honey, and 0.005-0.015 g of borneol. The chronic pharyngitis oral liquid is prepared by crushing artificial bezoar, musk, and whole worm into fine powder, taking the ingredients according to the above ratio, and uniformly stirring. The chronic pharyngitis oral liquid has no toxic and side effects, and the clinical verification of 500 patients shows that the cure rate is 100 %.
Description
Technical field
The present invention relates to oral liquid, especially a kind of chronic pharyngitis oral liquid.
Background technology
Mainly be the foreign body sensation of throat, do not increase and also be unable to come down, also often with nausea and vomiting, when especially brush teeth morning, simultaneously with dry cough, expectoration.Clinical manifestation is: xerostomia, bitter taste larynx are dry, itching throat cough, red swelling and pain of throat, expectorant color are white, sometimes with more or less strong viscous secretion.
At present, the treatment chronic pharyngitis is the antibiotic medicine with Western medicine generally.As everyone knows, Western medicine is cured the symptoms, not the disease, and the state of an illness easily repeatedly.Therefore, studying a kind of chronic rhinitis oral liquid that can cure chronic rhinitis, is the present technical issues that need to address.
Summary of the invention
Technical problem to be solved by this invention provides a kind of chronic rhinitis oral liquid that can cure chronic rhinitis.
The technical scheme that the present invention solves its technical problem is:
The chronic pharyngitis oral liquid; Its constituent is: artificial Calculus Bovis 0.01g, Moschus 0.01g, Scorpio 0.5g, Herba Taraxaci dry powder 0.5g, Flos Lonicerae dry powder 0.2g, Mel 60g, its processing technology of Borneolum Syntheticum 0.01g are: at first artificial Calculus Bovis, Moschus, Scorpio are ground into fine powder; Measure each component then according to the above ratio, stirring gets final product.
The optimal technical scheme that the present invention solves its technical problem is:
Its constituent is: artificial Calculus Bovis 0.01g, Moschus 0.01g, Scorpio 0.5g, Herba Taraxaci dry powder 0.5g, Flos Lonicerae dry powder 0.2g, Mel 60g, Borneolum Syntheticum 0.01g.
Therapeutic Method:
With ointment obliterating of the present invention affected part, drink half an hour once, can fully recover in 3 days.
Compared with prior art, the present invention is easy to use, has no side effect, and is clinical through 500 routine patients, cure rate 100%.
Specify therapeutic effect of the present invention through several model cases below:
Case one, the field so-and-so, man, 23 years old, area just outside a city gate town, Quzhou County, Hebei people from North Street, chronic pharyngitis.Oral oral liquid of the present invention, recovery from illness on the 3rd was not recurred after the recovery from illness.
Case two, Zhao so-and-so, the woman, 33 years old, western fort people, chronic pharyngitis were opened by Yongnian County, Hebei.Oral oral liquid of the present invention, recovery from illness on the 3rd was not recurred after the recovery from illness.
Case three, Lee so-and-so, man, 24 years old, beam tube people from town, Daming County, Hebei, chronic pharyngitis.Oral oral liquid of the present invention, recovery from illness on the 3rd was not recurred after the recovery from illness.
Case four, military so-and-so, woman, 17 years old, Handan City's Congtai District, chronic pharyngitis.Oral oral liquid of the present invention, recovery from illness on the 3rd was not recurred after the recovery from illness.
Case five, Hao so-and-so, woman, 20 years old, the Hanshan District people of Handan City, chronic pharyngitis.Oral oral liquid of the present invention, recovery from illness on the 3rd was not recurred after the recovery from illness.
The specific embodiment
Enumerate 10 specific embodiments of the present invention through the mode of tabulation below; Whole compositions are market and directly buy; Its processing technology is: at first artificial Calculus Bovis, Moschus, Scorpio are ground into fine powder, measure each component then according to the above ratio, stirring gets final product.Unit: g
| ? | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| The artificial Calculus Bovis | 0.005 | 0.014 | 0.009 | 0.015 | 0.01 | 0.014 | 0.01 | 0.006 | 0.008 | 0.015 |
| Moschus | 0.005 | 0.014 | 0.009 | 0.015 | 0.01 | 0.014 | 0.01 | 0.006 | 0.008 | 0.015 |
| Scorpio | 0.25 | 0.7 | 0.55 | 0.4 | 0.5 | 0.65 | 0.6 | 0.3 | 0.65 | 0.75 |
| The Herba Taraxaci powder | 0.25 | 0.7 | 0.55 | 0.4 | 0.5 | 0.65 | 0.6 | 0.3 | 0.65 | 0.75 |
| Flos Lonicerae | 0.1 | 0.25 | 0.15 | 0.3 | 0.2 | 0.1 | 0.25 | 0.3 | 0.15 | 0.3 |
| Mel | 40 | 70 | 55 | 40 | 60 | 65 | 45 | 50 | 65 | 80 |
| Borneolum Syntheticum | 0.005 | 0.014 | 0.009 | 0.015 | 0.01 | 0.014 | 0.01 | 0.006 | 0.008 | 0.015 |
Claims (2)
1. chronic pharyngitis oral liquid; It is characterized in that: its constituent is: artificial Calculus Bovis 0.005～0.015g, Moschus 0.005～0.015g, Scorpio 0.25～0.75g, Herba Taraxaci dry powder 0.25～0.75g, Flos Lonicerae dry powder 0.1～0.3g, Mel 40～80g, its processing technology of Borneolum Syntheticum 0.005～0.015g are: at first artificial Calculus Bovis, Moschus, Scorpio are ground into fine powder; Measure each component then according to the above ratio, stirring gets final product.
2. the polypous ointment of a kind of treatment according to claim 1, it is characterized in that: its constituent is: artificial Calculus Bovis 0.01g, Moschus 0.01g, Scorpio 0.5g, Herba Taraxaci dry powder 0.5g, Flos Lonicerae dry powder 0.2g, Mel 60g, Borneolum Syntheticum 0.01g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110436508.2A CN102512478B (en) | 2011-12-23 | 2011-12-23 | Chronic pharyngitis oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110436508.2A CN102512478B (en) | 2011-12-23 | 2011-12-23 | Chronic pharyngitis oral liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512478A true CN102512478A (en) | 2012-06-27 |
| CN102512478B CN102512478B (en) | 2014-06-18 |
Family
ID=46283731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110436508.2A Expired - Fee Related CN102512478B (en) | 2011-12-23 | 2011-12-23 | Chronic pharyngitis oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512478B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101708239A (en) * | 2009-03-16 | 2010-05-19 | 吴广记 | Low-sugar Kouyanning tablet |
-
2011
- 2011-12-23 CN CN201110436508.2A patent/CN102512478B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101708239A (en) * | 2009-03-16 | 2010-05-19 | 吴广记 | Low-sugar Kouyanning tablet |
Non-Patent Citations (1)
| Title |
|---|
| 张勉等: "中医中药治疗慢性咽炎近况", 《河北中医》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512478B (en) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101167947A (en) | Traditional Chinese medicine for treating acute pharyngitis | |
| CN101129620A (en) | Traditional Chinese medicine for treating nasosinusitis headache | |
| CN101152385A (en) | Traditional Chinese medicine for treating acute suppurative otitis media | |
| CN101129573A (en) | Traditional Chinese medicine for treating acute bronchitis | |
| CN101129668A (en) | Traditional Chinese medicine for treating infantile common cold | |
| CN101152218A (en) | Traditional Chinese medicine for treating chronic suppurative otitis media | |
| CN102283915B (en) | Chinese medicine for treating rhinitis | |
| CN103550450B (en) | Pure traditional Chinese medicine oral liquid for treating asthma | |
| CN102512478B (en) | Chronic pharyngitis oral liquid | |
| CN101390977A (en) | Oral liquid special for treating acute tonsillitis | |
| CN101670050A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN101152429A (en) | Traditional Chinese medicine for treating severe encephalitis B | |
| CN104645016A (en) | Traditional Chinese medicine spray for treating oral and laryngeal diseases | |
| CN101152483A (en) | Traditional Chinese medicine for treating adult measles in early eruption stage | |
| CN1772277A (en) | Cold treating medicine | |
| CN101138605A (en) | Traditional Chinese medicine for treating summer-heat-dampness cold | |
| CN101104023A (en) | Traditional Chinese medicine for treating infant diaper rash | |
| CN103989919A (en) | Traditional Chinese medicine composition for relieving cough and resolving phlegm | |
| CN103830644A (en) | Traditional Chinese medicine composition for treatment of pulpitis | |
| CN109010490B (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN101361900B (en) | Medicine for treatment of comedo | |
| CN101167825A (en) | Traditional Chinese medicine for treating otitis media in children | |
| CN101167917A (en) | Traditional Chinese medicine for treating aural vertigo | |
| CN102755609B (en) | Plaster for treating bronchitis | |
| CN102370806A (en) | Snake medicinal liquor liniment for treating chilblains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: HEBEI UNIVERSITY OF ENGINEERING Free format text: FORMER OWNER: ZHANG JINGZHEN Effective date: 20140303 |
|
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Geng Jianfang Inventor after: Xiao Yuesheng Inventor after: Zhang Jingzhen Inventor after: Liu Zhijun Inventor after: Geng Jianping Inventor after: Zhou Zhendong Inventor after: Qin Bing Inventor after: Xiao Xuan Inventor after: Gan Lu Inventor before: Zhang Jingzhen |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 056002 HANDAN, HEBEI PROVINCE TO: 056038 HANDAN, HEBEI PROVINCE Free format text: CORRECT: INVENTOR; FROM: ZHANG JINGZHEN TO: GENG JIANFANG XIAO YUESHENG ZHANG JINGZHEN LIU ZHIJUN GENG JIANPING ZHOU ZHENDONG QIN BING XIAO XUAN GAN LU |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20140303 Address after: 056038 Guangming South Street, Hebei, Handan, No. 199 Applicant after: Hebei University of Engineering Address before: 056002 Hebei Province, Handan city Congtai District Guangsha District 2 Building 2 unit 2 Lou Xi Hu Applicant before: Zhang Jingzhen |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140618 Termination date: 20141223 |
|
| EXPY | Termination of patent right or utility model |